,79 Cholesteryl ester transfer protein (CETP) inhibitors are being developed for treatment of cardiovascular diseases,80 and vigilance for increased risk of AMD incidence or progression in treated patients may be appropriate. This evidence concerns the gene CETP and age-related macular degeneration.